US Research Cuts Push Scientists to Leave for Positions Abroad

Scientists are leaving the United States for research positions abroad, and they point to one cause above all: the Trump administration's cuts to federal research funding, Fortune reports.

The headline verdict from the coverage is blunt. "I don't think here is our home anymore," one departing scientist told the outlet, capturing a sentiment that the report says is driving researchers to seek labs, institutes and faculties outside the US.

Who is leaving, and why now?

The Fortune report centers on researchers responding to reductions in US federal science spending under the current administration. Budget and grant uncertainty, not personal preference, emerges as the deciding factor for the scientists profiled. Their departures add up to a slow-motion transfer of trained talent to laboratories in Europe and elsewhere — though the report's headline framing does not itself quantify the total number of relocating researchers.

For R&D managers at US institutions, the practical risk is concrete. Every departing principal investigator takes grant history, instrument expertise and ongoing project leadership out of the building. Recruitment pipelines run in both directions: a lab that cannot promise stable funding loses candidates to countries that can.

What does this mean for US labs and budgets?

The report frames the exodus as a direct consequence of policy decisions on research appropriations. Scientists quoted in the coverage describe the funding environment as one that no longer supports a long-term career in the United States, which is why the relocation decisions are happening now rather than at retirement or sabbatical points.

That distinguishes this wave from ordinary international mobility. When researchers move because grants have been cut, the receiving institutions gain ready-built teams and reputations at effectively zero recruitment cost, while US portfolio holders absorb the loss of sunk investment in those same careers.

What comes next?

Whether the trend reverses depends on appropriations decisions still ahead. Until federal research funding stabilizes, US lab directors should expect continued pressure on retention — and European institutions should expect applications.